Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2026 is 24.40% vs -21.05% in Jun 2026
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2026 is 38.05% vs -45.39% in Jun 2026
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2026 is 29.50% vs -21.25% in Jun 2026
Interest
QoQ Growth in quarter ended Sep 2026 is 26.19% vs 9.03% in Jun 2026
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026
Compare Quarterly Results Of Sudarshan Pharma With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2026 is 24.40% vs -21.05% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 28.48% vs 31.33% in Sep 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2026 is 38.05% vs -45.39% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 93.54% vs -28.91% in Sep 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2026 is 29.50% vs -21.25% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 123.56% vs -29.37% in Sep 2025
Quarterly - Interest
QoQ Growth in quarter ended Sep 2026 is 26.19% vs 9.03% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 74.41% vs 60.54% in Sep 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026
YoY Growth in quarter ended Sep 2026 has improved from Sep 2025